Preparation of two triflate precursors for O-(2-[18F] fluoroethyl)-L-tyrosine used in positron emission tomography (PET)

被引:6
作者
Liu ChunYan [1 ,2 ]
Jiang ShenDe [1 ]
机构
[1] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China
[2] N China Coal Med Coll, Dept Pharm, Tangshan 063000, Peoples R China
来源
SCIENCE IN CHINA SERIES B-CHEMISTRY | 2009年 / 52卷 / 12期
关键词
positron emission tomography; triflate; L-tyrosine; 18F]FET precursor; PET imaging; F-18-LABELED AMINO-ACID; MAGNETIC-RESONANCE; TUMOR; TRACER; CANCER;
D O I
10.1007/s11426-009-0195-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Two novel triflate precursors for radiolabelling of L-tyrosine in positron emission tomography (PET) for tumor imaging, O-(2-trifluoromethanesulfonyloxyethyl)-N-(tert-butoxycarbonyl)-L-tyrosine methyl ester 9a and O-(2-trifluoromethanesulfonyloxyethyl)-N-(tert-butoxycarbonyl)-L-tyrosine tert-butyl ester 9b, are synthesized. The triflate agent, 9a or 9b, is prepared by esterification of methanol or transesterification of tert-butyl acetate with L-tyrosine, protection of the amine group with di-tert-butyl dicarbonate, alkylation with chlorohydrin, and triflation with trifluoromethanesulfonic anhydride in four steps with overall yields of 30% and 15%, respectively.
引用
收藏
页码:2195 / 2199
页数:5
相关论文
共 21 条
[1]   Designing novel contrast agents for magnetic resonance imaging. Synthesis and relaxometric characterization of three gadolinium(III) complexes based on functionalized pyridine-containing macrocyclic ligands [J].
Aime, S ;
Gianolio, E ;
Corpillo, D ;
Cavallotti, C ;
Palmisano, G ;
Sisti, M ;
Giovenzana, GB ;
Pagliarin, R .
HELVETICA CHIMICA ACTA, 2003, 86 (03) :615-632
[2]   Poly(ε-caprolactone) macroligands with β-diketonate binding sites:: synthesis and coordination chemistry [J].
Bender, JL ;
Shen, QD ;
Fraser, CL .
TETRAHEDRON, 2004, 60 (34) :7277-7285
[3]  
Coleman RE, 2005, J NUCL MED, V46, P1225
[4]   Fluorinated tracers for imaging cancer with positron emission tomography [J].
Couturier, O ;
Luxen, A ;
Chatal, JF ;
Vuillez, JP ;
Rigo, P ;
Hustinx, R .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (08) :1182-1206
[5]  
Gambhir SS, 2001, J NUCL MED, V42, p1S
[6]  
Hamacher K., 2001, Journal of Labelled Compounds and Radiopharmaceuticals, V44, pS855
[7]   Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine [J].
Hamacher, K ;
Coenen, HH .
APPLIED RADIATION AND ISOTOPES, 2002, 57 (06) :853-856
[8]  
Heiss P, 1999, J NUCL MED, V40, P1367
[9]   Whole-body FDG-PET imaging in the management of patients with cancer [J].
Hustinx, R ;
Bénard, F ;
Alavi, A .
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (01) :35-46
[10]  
Jager PL, 2001, J NUCL MED, V42, P432